These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24414883)

  • 41. Antipsychotic medication for early episode schizophrenia.
    Bola J; Kao D; Soydan H
    Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD006374. PubMed ID: 21678355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aripiprazole for schizophrenia.
    El-Sayeh HG; Morganti C
    Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD004578. PubMed ID: 16625607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective noradrenaline reuptake inhibitors for schizophrenia.
    Matthews PRL; Horder J; Pearce M
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010219. PubMed ID: 29368813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mirtazapine adjunct for people with schizophrenia.
    Perry LA; Ramson D; Stricklin S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011943. PubMed ID: 29802811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quetiapine versus typical antipsychotic medications for schizophrenia.
    Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
    Temmingh HS; Williams T; Siegfried N; Stein DJ
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antioxidant treatments for schizophrenia.
    Magalhães PV; Dean O; Andreazza AC; Berk M; Kapczinski F
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008919. PubMed ID: 26848926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Zuclopenthixol versus placebo for schizophrenia.
    Lacey M; Jayaram MB
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010598. PubMed ID: 26624987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Brooke-Powney MJ; Li X; Adams CE
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009377. PubMed ID: 28758203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Hussein M; Ahmed U; Rehman FU; Miramontes K; Adams CE
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009412. PubMed ID: 29634083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benzodiazepines for antipsychotic-induced tardive dyskinesia.
    Bergman H; Bhoopathi PS; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000205. PubMed ID: 29352477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological treatment for antipsychotic-related constipation.
    Every-Palmer S; Newton-Howes G; Clarke MJ
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011128. PubMed ID: 28116777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Rathbone J; Dardennes R; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2005 Apr; (2):CD001359. PubMed ID: 15846619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders.
    Ibragimov K; Keane GP; Carreño Glaría C; Cheng J; Llosa AE
    Cochrane Database Syst Rev; 2024 Jul; 7(7):CD013425. PubMed ID: 38958149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depot fluspirilene for schizophrenia.
    Abhijnhan A; Adams CE; David A; Ozbilen M
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001718. PubMed ID: 17253464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benzodiazepines for schizophrenia.
    Volz A; Khorsand V; Gillies D; Leucht S
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006391. PubMed ID: 17253592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluphenazine (oral) versus placebo for schizophrenia.
    Matar HE; Almerie MQ; Sampson S
    Cochrane Database Syst Rev; 2013 Jul; 7(7):CD006352. PubMed ID: 23861067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benzodiazepines for schizophrenia.
    Dold M; Li C; Tardy M; Khorsand V; Gillies D; Leucht S
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD006391. PubMed ID: 23152236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.